We read with interest the results of the HARMONi-6 trial by Zhiwei Chen and colleagues,1 which showed that ivonescimab plus chemotherapy improved progression-free survival versus tislelizumab plus ...
Abstract: Biohybrid microrobots, which merge living biological matter with synthetic components, hold immense promise to revolutionize medicine by acting as targeted therapeutic agents. A fundamental ...
Abstract: Multiple quadrotor aircraft system has significant advantages for performing complex tasks in dangerous environments, but it is still challenging for formation with external disturbance or ...
Ph!l and P!nk. Photo-Illustration: Vulture; Photos: Getty Images (Elena Di Vincenzo/Archivio Elena Di Vincenzo/Mondadori, Amy E. Price) If you, like us, have a list of snubs constantly running through ...
CEO Matthijs Glastra stated that "Novanta posted record revenue in the fourth quarter with 9% reported growth, 2% organic growth and 4% sequential growth. Bookings surged 25% year-over-year and 12% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results